About

Our focus is on the food and beverage, nutritional supplements, cosmetics, medical devices, and pharmaceutical industries. We provide complete legal services for the lifecycle of products aimed at improving the population’s health and wellness.

Amin Wasserman Gurnani has gained a strong reputation for its work at the cutting edge of food, drug (FDA), advertising (FTC/National Advertising Division/Direct Selling Self-Regulatory Council), and intellectual property (IP) laws, responding nimbly to rapid changes in the regulatory climate and marketplace. We work with some of the most innovative products in this sphere, such as raw juices, allergy-free foods, botanical drugs, cosmeceuticals, and hemp products. We counsel on regulatory compliance and risk analysis, product development, and trademark and patent protection.

In addition to guiding our clients through the strategic development of new products through regulatory approvals to the marketplace, we advise on all post-launch processes to ensure labeling, advertising, safety, and manufacturing compliance requirements. We counsel on recalls, consumer false advertising class actions, trademark and patent infringement disputes, FDA, FTC, and state attorney general government investigations, commercial (breach of contract) litigation, unfair competition, Proposition 65, and matters before the National Advertising Division, Direct Selling Self-Regulatory Council, and Consumer Product Safety Commission. We also provide IP and compliance due diligence assessments in mergers/acquisitions and guide companies on IP freedom-to-operate opinions.

What Our Clients Say

"Their strength is their knowledge of the regulatory and legal hurdles and for finding the best regulatory fit for a product concept. They know the health care industry leaders and the agencies that regulate them. 

This firm excels at facilitating interactions with government regulatory and industry's self regulating bodies."

– CEO of Major Pharmaceutical Company

Jennifer Adams Quoted in “NARB Upholds NAD Ruling Against Olly’s Kids Chillax Advertising Claims”

NutraIngredients-USA turned to FTC & State Advertising Compliance Practice Group Co-Chair Jennifer Adams for comment on the latest in a series of cases spotlighting the intersection of clinical substantiation, demographic targeting, and compliance with advertising standards in the dietary supplements sector. Jennifer stated, “This case highlights that study design matters more than the results. NARB’s […]

see all news >